Industry News
Australian biotech market today 16.03.09
Cochlear, CSL, Resmed, Sonic Healthcare, Avexa, Novogen, Alchemia, Biotron [ + ]
Collective action against HIV
Neutralising antibodies against HIV isolated from memory B cells [ + ]
Liquid handling forum goes live
Liquid Handling Talk, an online forum dedicated to pipetting and automated liquid handling quality, was launched recently, providing a means for scientists to discuss liquid handling issues and developments with peers and specialists around the world.
[ + ]Generic opportunity for Alchemia
Alchemia’s partner files generic application for fondaparinux [ + ]
pSivida eyes Iluvian
Good early results for pSivida’s intra-vitreal insert [ + ]
Australian biotech market today 13.03.09
Alchemia, pSivida, CSL, Acrux, Cellestis [ + ]
NuSep erects NxGen prospectus
NuSep plans to raise cash for NxGen acquisition [ + ]
Hardy Instruments appoints director of global sales
Hardy Instruments has appointed Ric Rummel as Director of Global Sales, based out of its corporate headquarters in the US.
[ + ]A machine to accurately control chromosomal separation
University of Washington researchers are helping to understand a nanoscale machine that can separate chromosomes before cell division and could provide insight into chromosomal diseases, like Down Syndrome.
[ + ]No synaptic loss for Prana
Prana claims compound prevents loss of synapses in Alzheimer’s [ + ]
Biotech stocks down at noon
CSL, Prana Biotechnology, Novogen, Sigma Pharmaceuticals | [ + ]
Creating controlled 3D microtissues
Scientists at the US Department of Energy’s Lawrence Berkeley National Laboratory can control how cells connect and assemble into three-dimensional, multicellular microtissues.
[ + ]Biotech Stock Report 10.03.09
CSL, Living Cell Tech, Prana, ChemGenex | [ + ]
Old mum good, old dad bad
UQ research finds association between paternal age and inferior cognitive performance [ + ]
Progen-Avexa deal goes bung
Progen forced to drop Avexa merger after overwhelming no vote [ + ]